[CLDX] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
08-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -21.69%
YoY- -53.99%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 2,220 1,026 1,101 980 3,113 2,363 2,408 -1.34%
PBT -29,598 -31,980 -28,082 -23,140 -15,027 -11,334 -8,755 22.48%
Tax -790 -782 -2,260 -142 -105 -288 -248 21.27%
NP -29,598 -31,980 -28,082 -23,140 -15,027 -11,772 -9,087 21.72%
Tax Rate - - - - - - - -
Total Cost 31,818 33,006 29,183 24,120 18,140 14,135 11,495 18.47%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin -1,333.24 -3,116.96 -2,550.59 -2,361.22 -482.72 -498.18 -377.37 23.38%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS -4.41 -4.87 -4.71 -4.28 -3.79 -4.00 -4.27 0.53%
EPS Diluted -4.41 -4.87 -4.71 -4.28 -3.79 -4.00 -4.27 0.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.